Regarding m6A writers, the methyltransferases METTL3, METTL14, and ZC3H13 have been identified as potential biomarkers for early diagnosis of pulmonary fibrosis and as prognostic indicators for patients with pulmonary fibrosis [23–25]. This evidence concerns the gene METTL3 and pulmonary fibrosis.